// App-Quantinova.ai

2109-281 : ABSORB EXTEND: AN INTERIM REPORT ON THE 24-MONTH CLINICAL OUTCOMES FROM THE FIRST 450 PATIENTS ENROLLED

Researchers

Presenter

  • Didier Carrie

Principal Investigators

  • N/A

Medical Centers

  • Hopital Rangueil, Toulouse, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Coronary artery lesions

  • Diabetes

  • Angina

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved